[1] 周丹妮,卫若楠,康梦娇,等. 围绝经期综合征动物模型研究进展[J]. 中国实验方剂学杂志,2021,27(18):243-250. DOI:10.13422/j.cnki.syfjx.20211836.
[2] Vrselja A, Latifi A, Baber RJ,et al. Q-122 as a novel, non-hormonal, oral treatment for vasomotor symptoms in women taking tamoxifen or an aromatase inhibitor after breast cancer: a phase 2, randomised, double-blind, placebo-controlled trial[J]. Lancet. 2022,400(10364):1704-1711. DOI: 10.1016/S0140-6736(22)01977-8.
[3] Janssen I, Powell LH, Crawford S, et al. Menopause and the metabolic syndrome: the study of women's health across the nation[J]. Arch Intern Med, 2008 ,168(14):1568-1575.DOI: 10.1001/archinte.168.14.1568.
[4] Delamater L, Santoro N. Management of the perimenopausec[J]. Clin Obstet Gynecol, 2018,61(3):419-432.DOI: 10.1097/GRF.0000000000000389.
[5] Sturdee DW, Hunter MS, Maki PM,et al. The menopausal hot flush: a review[J]. Climacteric, 2017,20(4):296-305.DOI: 10.1080/13697137.2017.1306507.
[6] Liotta M, Escobar PF. Hormone replacement after breast cancer: is it safe?[J]. Clin Obstet Gynecol, 2011,54(1):173-179. DOI: 10.1097/GRF.0b013e3182083cbb.
[7] Duralde ER, Sobel TH, Manson JE. Management of perimenopausal and menopausal symptoms[J]. BMJ, 2023,382:e072612. DOI: 10.1136/bmj-2022-072612.
[8] Clarkson TB. Estrogen effects on arteries vary with stage of reproductive life and extent of subclinical atherosclerosis progression[J]. Menopause, 2007,14(3 Pt 1):373-384.DOI: 10.1097/GME.0b013e31803c764d.
[9] Sahni S, Lobo-Romero A, Smith T. Contemporary non-hormonal therapies for the management of vasomotor symptoms associated with menopause: a literature review[J]. touchREV Endocrinol, 2021,17(2):133-137.DOI: 10.17925/EE.2021.17.2.133.
[10] Wattiez AS, Sowers LP, Russo AF. Calcitonin gene-related peptide (CGRP): role in migraine pathophysiology and therapeutic targeting[J]. Expert Opin Ther Targets,2020 ,24(2):91-100. DOI: 10.1080/14728222.2020.1724285.
[11] 武鑫,王冬慧,高剑峰. 降钙素基因相关肽在突触可塑性调控和情绪记忆中的作用[J]. 生理学报,2020,72(3):399-406. DOI:10.13294/j.aps.2019.0067.
[12] Noguchi M, Ikarashi Y, Yuzurihara M, et al. Up-regulation of calcitonin gene-related peptide receptors underlying elevation of skin temperature in ovariectomized rats[J]. J Endocrinol, 2002,175(1):177-183.DOI: 10.1677/joe. 0.1750177.
[13] 翟俊杰,朱伯阳,孟祥松,等. 牡丹皮的本草考证[J]. 成都大学学报(自然科学版),2024,43(2):113-119. DOI:10.3969/j.issn.1004-5422.2024.02.001.
[14] 王婕,陈雯佳,林文武,等. 围绝经期综合征肾阴虚证大鼠汗液分泌及其生化指标的变化[J]. 中国实验动物学报,2024,32(6):712-720. DOI:10.3969/j.issn.1005-4847. 2024.06.004.
[15] 李凯. 更年期潮热病机及治法微探[J]. 光明中医,2016,31(7):909-911. DOI:10.3969/j.issn.1003-8914. 2016.07.002.
[16] Oliveira MA, Lima WG, Schettini DA, et al. Is calcitonin gene-related peptide a modulator of menopausal vasomotor symptoms?[J]. Endocrine, 2019 ,63(2):193-203. DOI: 10.1007/s12020-018-1777-z.
[17] 侯可赛,王林林,王洪波,等. 降钙素基因相关肽受体研究的新进展[J]. 生理科学进展,2019,50(5):396-400,后插1. DOI:10.3969/j.issn.0559-7765.2019.05.017.
[18] Garelja ML, Bower RL, Brimble MA, et al. Pharmacological characterisation of mouse calcitonin and calcitonin receptor-like receptors reveals differences compared with human receptors[J]. Br J Pharmacol, 2022,179(3):416-434.DOI: 10.1111/bph.15628.
[19] McLatchie LM, Fraser NJ, Main MJ, et al. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor[J]. Nature, 1998 ,393(6683):333-339. DOI: 10.1038/30666.
[20] Russell FA, King R, Smillie SJ, et al. Calcitonin gene-related peptide: physiology and pathophysiology[J]. Physiol Rev, 2014,94(4):1099-1142. DOI: 10.1152/physrev. 00034.2013.
[21] 雷雯.清心滋肾汤对围绝经期大鼠卵巢细胞凋亡线粒体途径Bcl-2、Bax及Cyto-c表达的影响[D].南京:南京中医药大学,2014.
[22] 辛文霞.围绝经期综合征的客观指标与中医辨证分型的相关性研究[D].济南:山东大学,2005.
[23] 赵俊娟,屈爱春.67例女性更年期综合征血液流变学指标的检测及其分析[J].中国微循环,2002(3):194.
[24] Chen L, Liu Y, Tang Z, et al. Radix angelica dahuricae extract ameliorates oestrogen deficiency-induced dyslipidaemia in ovariectomized (OVX) rats by modulating the gut microbiota and bile acid signalling[J]. Phytomedicine, 2022 ,107:154440. DOI: 10.1016/j.phymed.2022.154440.
[25] 汤星月. 自拟安更汤对肾阴虚型围绝经期综合征患者症状改善及性激素水平的影响[J]. 基层中医药,2022,1(3):34-39.
|